El-Sayed H. Ibrahim1, Laura Horwood1, Jadranka Stojanovska1, Luba Frank1, Anil Attili1, Hakan Oral1, and Frank Bogun1
1University of Michigan, Ann Arbor, MI, United States
Synopsis
This study examines whether MRI is safe in patients with
cardiac implantable electronic device (CIED) excluded from published protocols,
e.g. patients with abandoned leads or pacemaker dependency. A total of 162 MRI
scans were obtained in 142 consecutive patients with CIED’s. Cardiac scans were
performed in 94 patients and spinal/brain scans were performed in 47 patients.
Only one patient developed ventricular tachycardia during a spine scan and was
removed from the scanner for device reactivation without consequences. No other
adverse events were noted. The devices interrogated parameters essentially
remained the same immediately, 1-week after, and 3-months after the scans. BACKGROUND
MRI is often required for patients with cardiac implanted
electronic devices (CIED). MRI has been reported to be safe in these patients when
appropriate device programming changes are performed prior to the scan. Nevertheless,
prior protocols excluded patients with abandoned leads or pacemaker-dependency.
1,2
The goal of this study is to examine whether this protocol is applicable to a
consecutive group of patients including patient groups who were excluded in
prior reports.
METHODS
The protocol followed at our institution for MR imaging of
CIED patients is limited to 1.5T scanners, where the scan ordering is based on
necessity and absence of an alternative imaging modality. The device-related
relative contraindications include the presence of abandoned leads, pacemaker
dependency, and time to lead implant <6 weeks, with the possibility of the ordering
physician overruling these exclusions. The protocol and pre-MRI assessment
include interrogation of baseline device characteristics: threshold testing,
sensing, battery voltage and impedance as well as pacing dependency. A provider
with CIED management expertise assesses the baseline device information, where
the device is programmed according to the patients’ needs with tachyarrhythmia
detection and therapy disabled during the scan. The patients’ rhythm and vital
signs are monitored while the patient is in the scanner. Device reinterrogation
and reprogramming are performed after completion of the scan, as well as at
1-week and 3-months after imaging.
The cardiac
scans were performed to assess the existence of late-gadolinium enhancement
(LGE) prior to ventricular tachycardia (VT) ablation procedures. The imaging
protocol consists of cine short-axis and long-axis images (SSFP sequence, TR = 4.2 ms,
TE = 1.8 ms, resolution = 1.4×1.4 mm2,
slice thickness = 8 mm) as well as 2D LGE imaging (inversion recovery sequence,
TR = 6.7 ms, TE = 3.2 ms, resolution = 1.4×2.2 mm2,
slice thickness = 8 mm, specific absorption rate (SAR) limit = 2 W/Kg). The brain
imaging protocol included axial T2-weighted, T1-weighhted, and FLAIR images, as
well as axial and coronal post-contrast T1-weighted images (slice thickness/gap
= 5/1 mm, total scan time ~16 minutes). The spine imaging protocol included sagittal
and axial T2-weighted fast spin-echo, T1-weighted spin-echo, and post-contrast T1-weighted
spin-echo images (sagittal and axial slice thickness/gap = 4/0.4 mm and 5/2 mm, respectively,
total scan time ~15 minutes).
RESULTS
A total of 162 MRI scans were obtained in 142 consecutive
patients with CIED’s (106 patients had defibrillators and 36 patients had pacemakers,
as shown in Table 1). Twenty-nine patients were pacemaker-dependent and 11
patients had abandoned leads. Cardiac MRI scans were performed in 94 patients
and spinal/brain scans were performed in 47 patients. In one patient, 2 cardiac
scans were performed. In the cardiac scans, the images were non-diagnostic only
in 4 patients due to extensive artifacts from the implanted cardiac
defibrillator (ICD). In 65 patients, LGE was detected without artifacts. No LGE
was identified in 25 scans. In the brain/spine scans, eight patients underwent
multiple studies and one patient underwent 7 scans. All, except one,
brain/spinal scans were diagnostic without artifacts. Only one patient
developed VT during a spine scan and was removed from the scanner for device
reactivation, which terminated VT without consequences. No other adverse events
were noted. The device parameters essentially remained the same immediately, 1-week,
and 3-months after the scans, as shown in Table 2. No changes in the device
parameters occurred that required reprogramming of any device. Some significant
differences in the lead impedances were detected when the baseline impedances
were compared to the impedance 1-week after the scan in the atrial leads,
defibrillation lead, and coronary sinus pacing leads. Nevertheless, these changes
could not be detected at 3-months after the scan.
DISCUSSION and CONCLUSIONS
The present study demonstrates that cardiac and non-cardiac
MRI could be safely performed in patients with abandoned pacemaker and
defibrillator leads as well as in pacemaker-dependent patients. No major
adverse events occurred in these patients. In the analyzed cohort of 142
patients, only in one pacemaker-dependent patient, the heart rate dropped from
90 to 50 bpm during spinal imaging using a fast spin-echo sequence (SAR = 1.89W/Kg)
due to elevated noise rate of the ICD. In this patient, a prior cardiac scan
was performed a week earlier where no problems were observed, as the cardiac LGE
sequence has low SAR of 0.11W/Kg. Therefore, with the protocol described in
this study, MR imaging could be safely performed in CIED patients without exposing
the patients to risk, despite pacemaker dependency, presence of abandoned leads,
and other CIED contraindications. This study recommends that MR imaging be
available to more CIED patients who can benefit from it.
Acknowledgements
No acknowledgement found.References
1. Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation
of a protocol for magnetic resonance imaging of patients with implanted cardiac
devices. Ann Intern Med. 2011;155:415-424.
2. Nazarian S, Roguin A, Zviman MM, et al. Clinical
utility and safety of a protocol for noncardiac and cardiac magnetic resonance
imaging of patients with permanent pacemakers and implantable-cardioverter
defibrillators at 1.5 tesla. Circulation.
2006;114:1277-1284.